Orthopediatrics (KIDS) Income from Discontinued Operations (2019)
Orthopediatrics' (KIDS) quarterly Income from Discontinued Operations came in at -$1.1 million in Q4 2019, down 616.43% quarter-over-quarter from $213000.0 in Q3 2019.
Analysis
Orthopediatrics (KIDS) Income from Discontinued Operations (2019) Analysis & Trends
Orthopediatrics (KIDS) has reported Income from Discontinued Operations for 1 consecutive years, with -$1.1 million the latest figure, recorded in Q4 2019.
- On a quarterly basis, Income from Discontinued Operations changed N/A year-over-year to -$1.1 million in Q4 2019; TTM through Dec 2020 was -$1.1 million, a 5.16% decrease from a year earlier, with the FY2019 full-year figure at -$1.0 million, changed N/A from the prior year.
- Income from Discontinued Operations was -$1.1 million for Q4 2019 at Orthopediatrics, down from $213000.0 in the prior quarter.
- Over five years, Income from Discontinued Operations peaked at $213000.0 in Q3 2019 and troughed at -$1.1 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.42 Bn | 178.82 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.16 Bn | 118.94 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.45 Bn | 100.98 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.47 Bn | 65.93 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.46 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.95 Bn | 32.50 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn | - |
| 10 | Orthopediatrics | 527.60 Mn | 481.72 Mn | 52.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -1.10 Mn |
| Sep 30, 2019 | 213,000.00 |
| Jun 30, 2019 | -159,000.00 |